CHEMBRDG-BB 7959525(CAS#667403-46-5)
Introduction
CHEMBRDG-BB 7959525 is an organic compound with the chemical formula C11H10Cl2NO4. It is a white crystalline powder with a bitter taste. It has a molecular weight of 290.1g/mol.
CHEMBRDG-BB 7959525 has a variety of applications in medicine and chemistry. It is widely used as an intermediate in organic synthesis for the synthesis of various biologically active molecules. It can be used as the backbone or functional group of drug molecules for the synthesis of new drugs. In addition, it can also be used in the synthesis of dyes, pesticides and photosensitive substances.
The method for preparing CHEMBRDG-BB 7959525 can be obtained by reacting 2,5-dichlorobenzoic acid with glycine. In the reaction, 2,5-dichlorobenzoic acid is dissolved in sodium carbonate solution, glycine is added and heated, and the product is obtained after the reaction. During the preparation process, attention should be paid to safe operation, avoid contact with skin and inhalation of gas.
Regarding safety information, CHEMBRDG-BB 7959525 is an organic compound that may be hazardous. It should be stored in a sealed container, away from fire and oxidizing agents. Wear appropriate protective equipment such as chemical goggles and gloves during operation. If contact with skin or eyes occurs, rinse immediately with plenty of water and seek medical help.
It is worth noting that the above information is for reference only. If you want to have an in-depth understanding of the nature, use, method and safety information of CHEMBRDG-BB 7959525, it is recommended to consult relevant scientific literature or consult professionals.
Application
N-(2,5-Dichlorobenzoyl)glycine (Ixazomib Impurity 9, CAS 667403-46-5) is a key pharmaceutical impurity standard and reference material used in the quality control of Ixazomib, a proteasome inhibitor for multiple myeloma. As a certified analytical reference standard, it is essential for method development, method validation (AMV), quality control (QC) applications for Abbreviated New Drug Applications (ANDA), impurity profiling, and stability studies during commercial production of Ixazomib. This high-purity glycine derivative also serves as a pharmaceutical intermediate for the synthesis of antifungal and antibiotic APIs, as well as a research tool for proteasome inhibitor degradation pathways. Xinchem offers custom synthesis, custom chemical synthesis, and contract manufacturing of this high-purity reference standard with full analytical characterization, flexible scaling from R&D to commercial tons, and traceability to pharmacopeial standards (USP/EP). Contact us for a competitive quote and reliable global supply.
